PRAX Q3 2022 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$30M

Operating Income

-$44M

Net Income

-$44M

EPS (Diluted)

$-14.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$137M

Total Liabilities

$32M

Stockholders' Equity

$105M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$30M	$0	—
Operating Income	-$44M	-$45M	+1.1%
Net Income	-$44M	-$45M	+1.7%